Royal Bank of Canada
NMRD

Royal Bank of Canada’s Nemaura Medical, Inc. Common Stock NMRD Stock Holding History

Royal Bank of Canada’s Portfolio NMRD Stock Details NMRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-491
Closed – – 7874
2023
Q4 		$0 Buy
491
+223
+83% +$53 ﹤0.01% 7800
2023
Q3 		$0 Sell
268
-164
-38% -$114 ﹤0.01% 7834
2023
Q2 		$0 Buy
+432
New +$311 ﹤0.01% 7849
2022
Q4 		– Sell
-57
Closed – – 7948
2022
Q3 		$0 Buy
+57
New +$114 ﹤0.01% 8051
2021
Q3 		– Sell
-1,870
Closed -$19K – 7964
2021
Q2 		$19K Buy
1,870
+723
+63% +$6.9K ﹤0.01% 6598
2021
Q1 		$9K Buy
1,147
+675
+143% +$4.47K ﹤0.01% 6870
2020
Q4 		$2K Buy
472
+453
+2,384% +$1.75K ﹤0.01% 6888
2020
Q3 		$0 Buy
+19
New +$111 ﹤0.01% 7046

Other funds holding NMRD

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Royal Bank of Canada's NMRD Position: Q1 2024 in Review

Royal Bank of Canada sold out of Nemaura Medical, Inc. Common Stock (NMRD) in Q1 2024, closing a stake of 491 shares.

Royal Bank of Canada first reported a position in NMRD in Q3 2020 and held it in 8 quarters. The position peaked at $19K in Q2 2021. 2 funds tracked by Wall St. Rank hold NMRD as of Q1 2024.

  • Royal Bank of Canada reported no remaining Nemaura Medical, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Royal Bank of Canada sold 491 Nemaura Medical, Inc. Common Stock shares in Q1 2024.
  • Royal Bank of Canada first reported a position in Nemaura Medical, Inc. Common Stock in Q3 2020 and held it in 8 quarters.
  • Royal Bank of Canada's Nemaura Medical, Inc. Common Stock position peaked at $19K in Q2 2021.
  • 2 funds tracked by Wall St. Rank held Nemaura Medical, Inc. Common Stock as of Q1 2024.

Based on Royal Bank of Canada's 13F filing for Q1 2024, filed 15 May 2024.